OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

A review of immune checkpoint blockade in breast cancer
Benedetta Pellegrino, Chiara Tommasi, Olga Elisabetta Cursio, et al.
Seminars in Oncology (2021) Vol. 48, Iss. 3, pp. 208-225
Open Access | Times Cited: 14

Showing 14 citing articles:

The New Frontier of Immunotherapy: Chimeric Antigen Receptor T (CAR-T) Cell and Macrophage (CAR-M) Therapy against Breast Cancer
Giuseppe Schepisi, Caterina Gianni, Michela Palleschi, et al.
Cancers (2023) Vol. 15, Iss. 5, pp. 1597-1597
Open Access | Times Cited: 31

NR1D1 Stimulates Antitumor Immune Responses in Breast Cancer by Activating cGAS-STING Signaling
Na‐Lee Ka, Mi Kyung Park, Seung-Su Kim, et al.
Cancer Research (2023) Vol. 83, Iss. 18, pp. 3045-3058
Open Access | Times Cited: 18

Clinical and immunological relevance of SLAMF6 expression in the tumor microenvironment of breast cancer and melanoma
Takaaki Oba, Mark D. Long, Ken‐ichi Ito, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 4

Recent advances in biomimetic nanodelivery systems for cancer Immunotherapy
Jiawei Yang, Xueqi Li, Tongyu Li, et al.
Materials Today Bio (2025), pp. 101726-101726
Open Access

Tertiary Lymphoid Structures Are Associated with a Favorable Prognosis in High-Grade Serous Ovarian Cancer Patients
Ke Zhang, Xiao Xie, Lihao Zou, et al.
Reproductive Sciences (2023) Vol. 30, Iss. 8, pp. 2468-2480
Closed Access | Times Cited: 10

Intratumoral pro-oxidants promote cancer immunotherapy by recruiting and reprogramming neutrophils to eliminate tumors
Stephen J. Ralph, Maxwell Reynolds
Cancer Immunology Immunotherapy (2022) Vol. 72, Iss. 3, pp. 527-542
Open Access | Times Cited: 13

PD-1 monoclonal antibodies enhance the cryoablation-induced antitumor immune response: a breast cancer murine model research
Zepeng Yu, Xingwei Sun, Yaping He, et al.
International Journal of Hyperthermia (2023) Vol. 40, Iss. 1
Open Access | Times Cited: 6

AZI2 mediates TBK1 activation at unresolved selective autophagy cargo receptor complexes with implications for CD8 T-cell infiltration in breast cancer
Syn Kok Yeo, Michael Haas, Kanakaraju Manupati, et al.
Autophagy (2023) Vol. 20, Iss. 3, pp. 525-540
Open Access | Times Cited: 4

SLC35A2 expression drives breast cancer progression via ERK pathway activation
Xiaochen Yang, Yukai Tao, Yan Xu, et al.
FEBS Journal (2023) Vol. 291, Iss. 7, pp. 1483-1505
Closed Access | Times Cited: 4

Efficacy of Pembrolizumab and Biomarker Analysis in Patients with WGS-Based Intermediate to High Tumor Mutational Load: Results from the Drug Rediscovery Protocol
Birgit S. Geurts, Laurien J. Zeverijn, Lindsay V.M. Leek, et al.
Clinical Cancer Research (2024) Vol. 30, Iss. 17, pp. 3735-3746
Closed Access | Times Cited: 1

Engineered immunologic niche monitors checkpoint blockade response and probes mechanisms of resistance
Ravi M. Raghani, Russell Urie, Jeffrey Ma, et al.
ImmunoMedicine (2024) Vol. 4, Iss. 1
Open Access | Times Cited: 1

The Innate Immune Microenvironment in Metastatic Breast Cancer
Chiara Tommasi, Benedetta Pellegrino, Anna Diana, et al.
Journal of Clinical Medicine (2022) Vol. 11, Iss. 20, pp. 5986-5986
Open Access | Times Cited: 4

Analysis of C-X-C motif chemokine receptors in breast cancer: potential value in immunotherapy and prognostic prediction
Yutian Sun, Ming Yang, Qingyuan Zhang
Annals of Translational Medicine (2022) Vol. 10, Iss. 24, pp. 1379-1379
Open Access | Times Cited: 1

Page 1

Scroll to top